Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

ClinicalTrials.gov ID: NCT01546142

Public ClinicalTrials.gov record NCT01546142. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 1, 2026, 1:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of ATX-101 (Sodium Deoxycholate Injection) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Study identification

NCT ID
NCT01546142
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Kythera Biopharmaceuticals
Industry
Enrollment
516 participants

Conditions and interventions

Interventions

  • Deoxycholic acid injection Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2012
Primary completion
Apr 30, 2013
Completion
Jul 31, 2013
Last update posted
Jun 14, 2015

2012 – 2013

United States locations

U.S. sites
30
U.S. states
18
U.S. cities
29
Facility City State ZIP Site status
Investigational Site Little Rock Arkansas 72116
Investigational Site Beverly Hills California 90210
Investigational Site Los Angeles California 90067
Investigational Site Sacramento California 95817
Investigational Site San Francisco California 94115
Investigational Site Santa Monica California 90404
Investigational Site Englewood Colorado 80113
Investigational Site Coral Gables Florida 33146
Investigational Site Jacksonville Florida 32204
Investigational Site Chicago Illinois 60611
Investigational Site Naperville Illinois 60563
Investigational Site Carmel Indiana 46032
Investigational Site South Bend Indiana 46617
Investigational Site Lutherville Maryland 21093
Investigational Site Clinton Township Michigan 48038
Investigational Site Edina Minnesota 55424
Investigational Site St Louis Missouri 63141
Investigational Site Montclair New Jersey 07042
Investigational Site New York New York 10022
Investigational Site New York New York 10065
Investigational Site White Plains New York 10604
Investigational Site Charlotte North Carolina 28207
Investigational Site High Point North Carolina 27262
Investigational Site Cincinnatti Ohio 45255
Investigational Site Portland Oregon 97035
Investigational Site Austin Texas 78759
Investigational Site Plano Texas 75093
Investigational Site San Antonio Texas 78229
Investigational Site Salt Lake City Utah 84117
Investigational Site Charlottesville Virginia 22911

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01546142, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 14, 2015 · Synced May 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01546142 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →